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Key points
 Muscle glycogen and intramuscular triglycerides (IMTG, stored in lipid droplets) are important
energy substrates during prolonged exercise.
 Exercise-induced changes in lipid droplet (LD) morphology (i.e. LD size and number) have not
yet been studied under nutritional conditions typically adopted by elite endurance athletes, that
is, after carbohydrate (CHO) loading and CHO feeding during exercise.
 We report for the first time that exercise reduces IMTG content in both central and peripheral
regions of type I and IIa fibres, reflective of decreased LD number in both fibre types whereas
reductions in LD size were exclusive to type I fibres.
 Additionally, CHO feeding does not alter subcellular IMTGutilisation, LDmorphology ormuscle
glycogen utilisation in type I or IIa/II fibres.
 In the absence of alterations to muscle fuel selection, CHO feeding does not attenuate cell
signalling pathways with regulatory roles in mitochondrial biogenesis.
Abstract We examined the effects of carbohydrate (CHO) feeding on lipid droplet (LD)
morphology, muscle glycogen utilisation and exercise-induced skeletal muscle cell signalling. After a
36 h CHO loading protocol and pre-exercise meal (12 and 2 g kg–1, respectively), eight trainedmales
ingested 0, 45 or 90 g CHO h–1 during 180 min cycling at lactate threshold followed by an exercise
capacity test (150% lactate threshold). Muscle biopsies were obtained pre- and post-completion of
submaximal exercise. Exercise decreased (P < 0.01) glycogen concentration to comparable levels
(∼700 to 250 mmol kg–1 DW), though utilisation was greater in type I (∼40%) versus type II fibres
(∼10%) (P < 0.01). LD content decreased in type I (∼50%) and type IIa fibres (∼30%) (P < 0.01),
with greater utilisation in type I fibres (P < 0.01). CHO feeding did not affect glycogen or IMTG
utilisation in type I or II fibres (all P > 0.05). Exercise decreased LD number within central and
peripheral regions of both type I and IIa fibres, though reduced LD size was exclusive to type I
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fibres. Exercise induced (all P < 0.05) comparable AMPKThr172 (∼4-fold), p53Ser15 (∼2-fold) and
CaMKIIThr268 phosphorylation (∼2-fold) with no effects of CHO feeding (all P > 0.05). CHO
increased exercise capacity where 90 g h–1 (233 ± 133 s) > 45 g h–1 (156 ± 66 s; P = 0.06) > 0 g h–1
(108 ± 54 s; P = 0.03). In conditions of high pre-exercise CHO availability, we conclude CHO
feeding does not influence exercise-induced changes in LD morphology, glycogen utilisation or cell
signalling pathways with regulatory roles in mitochondrial biogenesis.
(Received 14 December 2020; accepted after revision 22 March 2021; first published online 26 March 2021)
Corresponding author J. P. Morton: Research Institute for Sport and Exercise Sciences (RISES), Liverpool JohnMoores
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Introduction
Muscle glycogen and intramuscular triglycerides (IMTG)
provide important energy substrates during prolonged
endurance exercise (Van Loon, 2004). In contrast to
glycogen, our understanding of IMTG storage and
metabolism during exercise is not as advanced and is often
complicated by the contrasting methodologies that have
been used to quantify IMTG content, that is, biochemical
triacylglycerol extraction, high-resolution electronmicro-
scopy or immunofluorescence microscopy. Using the
lattermethod, our laboratory (Shepherd et al. 2013; Jevons
et al. 2020) and others (Van Loon et al. 2003a,b; De Bock
et al. 2005; Stellingwerff et al. 2007a) have observed that
resting IMTG content is approximately twofold greater in
type I fibres compared with type IIa fibres, a reflection of
both a greater number and size of IMTG-containing lipid
droplets (LD) (Shepherd et al. 2013; Jevons et al. 2020).
In relation to exercise, reductions in IMTG content pre-
dominantly occur in type I fibres with smaller changes
in II/IIa fibres (Van Loon et al. 2003a,b; De Bock et al.
2005; Stellingwerff et al. 2007a,b; Van Proeyen et al.
2011; Shepherd et al. 2013; Jevons et al. 2020). We
recently reported that the reduction of IMTG within type
I fibres is underpinned by reduced LD number with no
difference in LD size (Jevons et al. 2020), though pre-
vious researchers have observed reductions in both LD
size and number (Stellingwerff et al. 2007a). From a sub-
cellular perspective, we also observed that prolonged end-
urance exercise reduces IMTG content in the central
region (indicative of the intermyofibrillar region) of type
I fibres but not the peripheral (i.e. subsarcolemmal)
region (Jevons et al. 2020). It is noteworthy, however,
that different methodological protocols may affect our
interpretation of the subcellular utilisation patterns of
IMTG, given that the choice of lipid dye (Oil Red O
versus BODIPY) and chosen size of peripheral region
(i.e. 2 versus 5 μm) may contribute additional artefacts
upon the quantification of changes in substrate pools
during exercise (Jevons et al. 2020; Strauss et al. 2020).
Collectively, such data demonstrate that further research is
required to further characterise the exercise-induced sub-
cellular changes in LD morphology within specific fibre
types.
The regulation of muscle fuel selection during
exercise has often been studied using exercise protocols
commenced in the fasted state (Romijn et al. 1993;
Van Loon et al. 2001). However, given the ergogenic
effects of CHO on exercise performance (Hawley et al.
1997; Stellingwerff & Cox, 2014), such an approach
often contrasts with the nutritional practices adopted by
athletic populations. Indeed, athletes will increase CHO
availability in the day(s) and hours before competition
so as to commence exercise with sufficient muscle and
liver glycogen stores (Burke et al. 2018). In addition, it is
now an established practice for elite endurance athletes to
also consume CHO during exercise, with contemporary
guidelines recommending CHO ingestion rates up to 90
gh−1 when exercise is greater than 2.5–3 h in duration
(Thomas et al. 2016). Although it is generally accepted
that CHO feeding induces ergogenic effects via liver
glycogen sparing (as opposed to muscle glycogen sparing;
Coyle et al. 1986; Gonzalez et al. 2015), the effects of
CHO feeding on fibre-specific IMTG utilisation during
exercise are conflicting. For example, De Bock et al. (2005)
observed an attenuated use of IMTG in type Imuscle fibres
when CHOwas consumed before (∼150 g) and during 2 h
moderate intensity cycling (∼75 g h−1) when compared
with exercise completed in the fasted state. In the absence
of a pre-exercise meal, however, Stellingwerff et al.
(2007a) observed no effect of CHO feeding (∼50 g h−1)
during 3 h of exercise upon net utilisation of IMTG
stores in either type I or II muscle fibres. As such, it is
possible that the effects of CHO feeding on the down
regulation of IMTG utilisation are only apparent in the
presence of a pre-exercise meal and/or when a larger
absolute CHO intake has been ingested. When taken
together, such studies clearly demonstrate the importance
of isolating the potential regulatory effects of CHO
feeding to that consumed ‘during’ exercise as opposed to
that induced by the pre-exercise meal. Additionally,
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the effects of CHO intake during exercise on the
subcellular changes in LD morphology have not yet been
studied.
Although CHO feeding is well established as ergogenic
for exercise performance (Stellingwerff & Cox, 2014),
there is a growing body of literature demonstrating that
CHO restriction before, during and/or after exercise can
up-regulate cell signalling pathways with putative roles
in training adaptation (Impey et al. 2018). The practical
application of such findings has been communicated
according to the train-low, compete-high paradigm
surmising that beneficial metabolic adaptations may be
induced by carefully selected periods of CHO restriction
around certain training sessions but that competition (and
indeed, high-intensity training sessions) should always
be commenced with high CHO availability (Impey et al.
2018). We (Morton et al. 2009) and others (De Bock
et al. 2005; Akerstrom et al. 2006; Lee-Young et al.
2006) have observed that CHO ingestion before and/or
during exercise may attenuate acute skeletal muscle cell
signalling and gene expression as well as training-induced
oxidative adaptations of human skeletal muscle. However,
such regulatory effects of CHO ingestion during exercise
may only manifest if the CHO feeding strategy has
induced muscle glycogen sparing (Akerstrom et al. 2006;
Lee-Young et al. 2006). Indeed, recent data from our
laboratory support the hypothesis that the enhanced
adaptations associated with train-low models of CHO
restriction are particularly dependent on the absolute
post-exercise glycogen concentration (Hearris et al. 2019,
2020). Accordingly, it is possible that consuming CHO
during exercise induces negligible effects on cell signalling
and training adaptation providing that no alterations
to muscle fuel selection and utilisation have actually
occurred.
With this in mind, the aim of the present study
was to test the following hypotheses: (1) CHO feeding
during prolonged endurance exercise does not affect
IMTG (and LD morphology) and muscle glycogen
utilisation in both type I and type II muscle fibres,
(2) CHO feeding does not impair the activation of
skeletal muscle cell signalling pathways with regulatory
roles in training adaptation and, (3) CHO feeding
improves exercise capacity in a dose dependent manner.
To this end, trained male cyclists completed 180 min
of steady-state submaximal exercise (followed by an
exhaustive high-intensity capacity test) during which they
consumed 0, 45 or 90 g CHO h−1, comprising a mixture
of fluids, solids and gels. Importantly, each experimental
trial was commenced after a 36-h CHO loading protocol
(12 g kg−1) and 3 h after consumption of a pre-exercise
meal that was rich in CHO (2 g kg−1). In this way,
our experimental approach allowed us to isolate the
potential regulatory effects of CHO to that consumed




All participants gave written informed consent prior
to participation after all experimental procedures and
potential risks had been fully explained. The study was
approved by the Ethics Committee of Liverpool John
MooresUniversity (EthicsNo: 16 SPS 030) and conformed
to the standards set by the latest revision of theDeclaration
of Helsinki (except for registration in a database).
Participants
Eight endurance-trained amateur male cyclists
(mean ± SD: age, 31 ± 7 years; body mass 73.6 ± 6.1 kg;
height, 177.0 ± 8.0 cm) volunteered to participate in
the study. Mean V̇O2 max, peak power output (PPO)
and power output at lactate threshold (LT) were
60.5 ± 5.4 ml kg−1min−1, 383 ± 21 W and 208 ± 11 W,
respectively. Subjects were defined as trained in
accordance with the criteria specified by Jeukendrup
et al. (2000). None of the subjects had any history of
musculoskeletal or neurological disease nor were they
under any pharmacological treatment or using any
nutritional supplements in the lead up to and during the
course of the testing period.
Experimental overview
In a repeated-measures, randomised, cross-over design
separated by 7–8 days, participants completed four
prolonged endurance-based cycling exercise protocols
which consisted of 180 min steady-state submaximal
exercise (undertaken at LT) followed by a exercise capacity
test to exhaustion (undertaken at 150% of LT). The initial
trial was a full familiarisation with the exercise protocol
(where water only was consumed during exercise) and in
the following three trials, subjects ingested CHO at a rate
of 0, 45 or 90 g h−1 in the form of solids, gels and fluids
during the exercise bouts. These CHO ingestion regimens
replicated the typical feeding patterns of professional
cyclists during competition (Heikura et al. 2019; Muros
et al. 2019). Each experimental trial was commenced
after a 36-h CHO loading protocol (12 g kg−1) and 3 h
after consumption of a pre-exercise meal that was rich
in CHO (2 g kg−1). Muscle biopsies were obtained from
the m. vastus lateralis immediately before and at the
end of the 180 min submaximal cycle (the 180 min time
point biopsy was obtained prior to commencing the
© 2021 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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exercise capacity test). An overview of the experimental
design and nutritional protocols are displayed in
Fig. 1.
Preliminary testing
At least 7 days prior to experimental trials, all sub-
jects performed a two-part incremental cycle test (Lode
Excalibur Sport, Groningen, Netherlands) to determine
LT, maximal oxygen consumption (V̇O2 max) and PPO
(similar to that described inNewell et al. 2015). Briefly, the
first part of the incremental cycling test was commenced
at 125 W and each stage increased by 25 W every 4 min
with a capillary blood sample (fingertip) being obtained
for blood lactate concentration analysis by micro-assay
(Lactate Pro 2, ArkRay Inc., Kyoto, Japan) during the
last 30 s of each stage. The LT and lactate turn-point
(LTP) were defined as the first and second sustained
increases in blood lactate above baseline values (Carter
et al. 1999). The mean (± SD) lactate concentration at
LT was 1.7 ± 0.3 mmol l−1 corresponding to an intensity
of 55 ± 3% of PPO and 64 ± 3% of V̇O2 max. The test
end time and power output of the final stage from the
second part of the incremental cycling test was used to
calculate PPO using the following equation (Kuipers et al.
1985):
PPO = Wfinal + ([t/60] · PI) ,
where Wfinal is the power output of the final completed
stage inwatts, t is time spent in the final uncompleted stage
(seconds), 60 is the duration of each stage (seconds) and
PI is the increase in power output between each stage (W).
V̇O2 max was assessed via an automated online gas analyser
(Moxus Modular Metabolic System, AEI Technologies,
Pittsburgh, PA, USA) and was determined as the highest
average V̇O2 captured over a 30 s period. The same auto-
mated online gas analyser was used in all subsequent
trials.
Familiarisation and experimental protocols
At least 7 days prior to the main experimental trials,
subjects undertook a full familiarisation with the
experimental trial (detailed below) where they refrained
from CHO intake during the submaximal cycling
protocol, thus replicating the same nutritional conditions
as per the 0 g h−1 trial (without blood samples andmuscle
biopsies being taken). The familiarisation trial served to
Figure 1. Schematic overview of the experimental protocol employed in each trial
On the evening of day 1, participants completed a glycogen depleting cycling protocol followed by a high
carbohydrate (CHO) diet in the hours before sleep. Throughout the entirety of day 2, participants consumed a high
CHO diet. During the main experimental trial on day 3, subjects consumed a high CHO pre-exercise meal before
undertaking 180 min steady-state submaximal exercise whereby they consumed 0, 45 or 90 g h−1 CHO followed
by a time to exhaustion (TTE) exercise capacity test. Muscle biopsies were obtained immediately pre-exercise and
at the end of the 180 min submaximal exercise. PRO, protein.
© 2021 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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introduce participants to the research design, verify the
subject’s ability to complete the prescribed intensity of the
180 min submaximal ride and also provide baseline data
for the exercise capacity test.
Day 1: glycogen depletion protocol
At 36 h before the main experimental trial (i.e. evening
of Day 1), subjects reported to the laboratory at
approximately 18.00 to perform a 90 min bout of
intermittent glycogen depleting cycling, as previously
described with in our laboratory (Taylor et al. 2013). The
activity pattern and total time to exhaustion (TTE) for the
glycogen depleting ride was recorded for each participant
during their first trial and replicated for the remainder
of the trials. This intermittent pattern of exercise was
employed in an attempt to induce glycogen depletion in
both type I and II fibres. To facilitate the goal of CHO
loading, subjects consumed high CHO snacks/fluids (SiS
GO Energy, SiS REGO Protein, SiS GO Bars, Science in
Sport, Blackburn, UK) and food (pasta and tomato-based
sauce) immediately and at 1 h and 2 h post glycogen
depletion exercise (see Fig. 1).
Day 2: CHO loading regimen
Over the course of the following day (i.e. Day 2),
participants were provided with a pre-packaged
standardised high CHO diet (i.e. breakfast cereals,
breads, pasta, rice, confectionary products) to consume
throughout the entirety of that day (see Fig. 1) and also
refrained from any strenuous physical activity and alcohol
consumption. Fluid intake was restricted to water only
and was allowed ad libitum.
Day 3: familiarisation and experimental trials
On the morning of the main experimental trials at
∼08.00 h, subjects reported to the laboratory in a fasted
state and were immediately provided with a standardised
high-CHO breakfast (see Fig. 1). At 3 h post-prandial
and immediately before the beginning of the cycling
protocol, an indwelling cannula (Safety Lock 22G, BD
Biosciences, West Sussex UK) was inserted into the
antecubital vein in the anterior crease of the forearm
and a resting blood sample drawn. After a resting blood
sample was taken, the cannula was flushed with ∼5 ml
of sterile saline (Kays Medical supplies, Liverpool, UK) to
keep the cannula patent and sterile, this procedure was
repeated after each subsequent blood draw. Participants
then completed a 10 min warm-up at 100 W and began
the 180 min cycle preload at LT (208 ± 11 W). LT was
chosen as the exercise intensity given it has been suggested
as an appropriate method of matching metabolic stress
between participants when compared to exercising at
a percentage of V̇O2 max (Baldwin et al. 2000). Heart
rate (Polar H7, Kempele, Finland), RPE and cycling
cadence were obtained at 30 min intervals throughout
the submaximal cycle. Expired gas was collected for
5 min at 30 min intervals in order to calculate substrate
oxidation. Venous blood samples were also collected at
30 min intervals throughout the 180 min submaximal
exercise.
During the 180 min submaximal ride, subjects
consumed 0, 45 or 90 g h−1 CHO (see Fig. 1). During
the 0 g h−1 trial, subjects received 125 ml of a lemon
flavoured drink containing no CHO (SiS GO Hydro,
Science in Sport, Blackburn, UK) at 20 min intervals,
beginning at 0 min (2 × 125 ml doses was provided
at 60 and 120 min). During the 45 g h−1 trial subjects
received the same fluid intake pattern as the 0 g h−1 trial
but also consumed a solid homemade CHO rice cake
every 30 min beginning at 0 min for the first 120 min
of exercise followed by a commercially available CHO
gel (SiS GO Isotonic Gel, Science in Sport) every 30 min
in the final hour of exercise, of which the final gel was
consumed at 150 min. During the 90 g h−1 trial, a solid
homemade CHO rice cake was provided at 20 min inter-
vals beginning at 0 min for the first 120 min of exercise
followed by a commercially available CHO gel at 20 min
intervals during the final hour of exercise, of which
the final gel was consumed at 160 min. Additionally,
125 ml of a bespoke lemon flavoured 4% CHO drink
(Science in Sport) was consumed at 20 min intervals
throughout the whole duration of the 90 g h−1 trial
(2 × 125 ml doses was provided at 60 and 120 min).
Immediately following the 180 min submaximal cycle
and after obtaining the post-exercise muscle biopsy,
participants had a brief warmup (5 min at 100 W)
and then immediately began the exercise capacity test
whereby they cycled at 150%LT (312± 15W) to volitional
exhaustion. No music was played and the only available
information to the participants was the fixed power output
and cadence. No performance results were shown to the
subjects until they had completed all of the experimental
trials. All exercise tests were performed at the same
time of day (11:00 ± 1 h) under normal laboratory
conditions (20–21˚C and 50–60% humidity) using the
same electrically braked cycle ergometer (Lode Excaliber
Sport, Groningen, Netherlands) and automated gas
analyser machineMoxusModularMetabolic System (AEI
Technologies, IL, USA). During all exercise trials, subjects
were cooled with a floor standing fan tominimise thermal
stress. Each experimental trial was separated by 7–8 days
and subjects were asked to continue with their habitual
training schedule during this period which equated to
03:21 ± 02:14 (hh:min) and 95 ± 67 km (excluding
the 90 min glycogen depletion and ∼180 min cycling
protocol). Full breakdown of nutritional compositions of
© 2021 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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the CHO feeding strategies are provided in the Appendix
available online in Supporting information.
Estimates of whole-body substrate oxidation and
total energy expenditure
Rates of whole-body CHO and fat oxidation (g min−1)
were calculated at 30 min intervals from each steady-state
gas sample collected throughout the 180 min sub-
maximal cycle (Jeukendrup & Wallis, 2005). Total energy
expenditure was estimated for each trial assuming an
energy yield of 17.57 kJ and 39.33 kJ for 1 g of CHO and
fat, respectively.
Blood sampling and analysis
Venous blood samples were collected into vacutainers
containingK2 EDTA, lithiumheparin or serum separation
tubes (BD Biosciences, UK). K2 EDTA and lithium
heparin tubes were stored on ice while serum separation
tube vacutainers were stored at room temperature, both
for 1 h before centrifugation at 1500 g for 15 min
at 4˚C. Following centrifugation, plasma and serum
was separated into 4 aliquots and stored at −80˚C
for subsequent analysis. Samples were later analysed
for plasma glucose, lactate, non-esterified fatty acids
(NEFA), glycerol and β-hydroxybutyrate (β-OHB) using
commercially available enzymatic spectrophotometric
assays (RX Daytona Analyser, Randox, Co. Antrim, UK)
as per the manufacturer’s instructions.
Muscle biopsies
Skeletal muscle biopsies (100–150 mg) were obtained
from the lateral portion of the m. vastus lateralis
immediately before (0 min) and immediately upon
completion of the 180 min steady-state submaximal
cycle (180 min) but before the exercise capacity test.
Muscle biopsies were obtained using the Weil-Blakesley
conchotome technique under local anaesthesia (0.5%
Marcaine) andwere taken from the same region and depth
on alternating legs, with incisions separated by ∼5 cm
with care to avoid damage from multiple biopsies. Once
collected, samples were quickly dissected from fat and
connective tissue and divided into multiple pieces on an
irradiated sterile Petri dish using surgically sterile tweezers
and a scalpel. A portion of the muscle tissue was then
prepared for immunohistochemical analysis (∼50 mg)
by embedding in Tissue-Tek OCT compound (Sakura
Finetek Europe, The Netherlands) on a cork board which
was immediately frozen in liquid nitrogen-cooled iso-
pentane (Sigma-Aldrich, Dorset, UK) before being stored
in aluminium cryotubes (LuBio Science, Switzerland)
which were subsequently submerged in liquid nitrogen
and stored at −80˚C for later analysis. The remaining
portions (for glycogen and signalling proteins) of the
muscle biopsy were also immediately frozen in liquid
nitrogen and stored at −80˚C for later analysis. The time
elapsed between the finish of the 180 min submaximal
exercise, having the muscle biopsy taken and returning
to the bike ergometer for the exercise capacity test was
∼5 min.
Muscle glycogen concentration
Whole muscle glycogen concentrations were determined
according to the acid hydrolysis method described by Van
Loon et al. (2000). Approximately 2–5 mg of freeze-dried
muscle tissue was powdered, dissected of all visible
blood and connective tissue and subsequently hydro-
lysed by incubation in 500 μl of 1 m HCl for 3 h
at 100˚C. After cooling to room temperature, samples
were neutralised by the addition of 250 μl 0.12 mol l−1
Tris-2.1 mol l−1 KOH saturated with KCl. Following
centrifugation, 200 μl of the supernatant was analysed
in duplicate for glucose concentration according to
hexokinase method using a commercially available kit
(GLUC-HK; Randox Laboratories, Antrim, UK).
Intramuscular triglyceride immunofluorescence
staining and analysis
Cryosections (5 μm) were cut using a microtome
(Bright Instrument Company Ltd, Huntingdon, UK)
housed within a cryostat at −25˚C. The sections were
collected onto uncoated, ethanol-cleaned glass slides
(VWR International Ltd, Leicestershire, UK). Sections
from both the 0 min and 180 min exercise time point
from one participant were placed on a single slide but
samples between trials were placed on separate slides to
account for any variation in staining intensity between
sections. Fibre type-specific IMTG content was quantified
using immunofluorescence staining as described pre-
viously from within our laboratory (Strauss et al. 2020).
Full details are provided in the Appendix (Supporting
information). For fluorescence immunohistochemistry,
antibodies targeting myosin heavy chain type I (MHCI;
a4.840c developed by Dr Blau, Developmental Studies
Hybridoma Bank (DSHB), Iowa City, IA, USA) and
myosin heavy chain type IIa (MHCIIa; n2.261c, DSHB)
were combined with secondary antibodies Alexa Fluor
goat anti-mouse (GAM) IgM 546 to visualise anti-MHCI
and Alexa Fluor GAM IgG 405 to visualise anti-MHC
IIa. Additionally, wheat germ agglutinin (WGA) Alexa
Fluor 633 conjugate (Invitrogen, Paisley, UK) was used
to identify the cell membrane (and used as a cell border
for the purposes of analysis) and BODIPY 493/503
© 2021 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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(Invitrogen, Paisley, UK, D3922) was used to visualise
IMTG.
Images of cross-sectionally orientated sections, used
to investigate fibre type-specific IMTG content and
lipid droplet (LD) morphology, were captured using
an inverted confocal microscope (Zeiss LSM710; Carl
Zeiss AG, Oberkochen, Germany) with a 63× (1.4 NA)
oil immersion objective. Type I and type IIa fibres
were identified through positive staining, and any fibres
without positive staining for either MHCI or MHCIIa
were assumed to be type IIx fibres. Although, some images
were captured for type IIx fibres, there was an insufficient
number to include within the data. Approximately 20
images were captured per time point, aiming for an even
split across type I and IIa fibres. Overall, 10 ± 1 fibres
were analysed per time point and condition for type I
fibres and 9 ± 1 fibres for type IIa fibres, equating to
approximately 111 ± 30 fibres per participant. Recent
work from our laboratory has revealed that imaging of at
least 10 fibres per fibre type per time point will generate
a reliable estimate of IMTG content which will be within
10% of a larger number of fibres (i.e. 20 type I and
15 type IIa fibres) (Strauss et al. 2020). Given that in
most acute and chronic training interventions the changes
expected in IMTG content will exceed 10% (Van Loon
et al. 2003a,b; Shepherd et al. 2013; Jevons et al. 2020),
we deemed that 10 fibres per fibre type per time point
would be time efficient without compromising the validity
of the data generated. Image processing was completed
using Image-Pro Plus 5.1 software (Media Cybernetics,
MD, USA). To assess IMTG content and LD morphology
on a fibre type-specific basis, the fibre was first separated
into a peripheral region to measure subsarcolemmal LD
(first 2 μm from the cell border) and the central region to
measure intermyofibrillar LD (remainder of the cell) (see
Fig. 2.). This approach of using a fixed 2μmdistance from
the membrane to represent the subsarcolemmal region
has been utilised previously to examine IMTG content in
differing populations (Van Loon, 2004; Jevons et al. 2020).
An intensity thresholdwas uniformly selected to represent
a positive signal for IMTG. The content of IMTG was
expressed as the positively stained area relative to the total
area of the peripheral or central region of each muscle
fibre. LD number was calculated as the number of IMTG
objects relative to area. Themean area of individual IMTG
objects (LDs) was used as a measure of LD size.
Muscle glycogen fibre-type histochemistry and
analysis
Fibre type-specific glycogen depletion was quantified by
combining a brightfield periodic acid-Schiff stain (PAS)
with an immunofluorescence myosin heavy chain (MHC)
stain on single cross-sections similar to the methodology
described elsewhere (Schaart et al. 2004). Full details
are provided in the Appendix (Supporting information).
PAS was used to visualise muscle glycogen; however, the
Schiff reagent (Sigma-Aldrich) was diluted to 25% in
PBS as a result of prior optimisation, given that when
we applied the reagent without any dilution the dye
intensity saturated the signal in both the 0 min and
180 min exercise time point samples. For fluorescence
immunohistochemistry, a primary antibody targeting
myosin heavy chain type I (MHCI; a4.840c developed by
Dr Blau, DSHB) was combined with a secondary anti-
body Alexa Fluor GAM IgM 488. Images of sections
used to investigate fibre type-specific muscle glycogen
were captured using a Leica DM6 B upright micro-
scope coupled to a Leica DFC7000 T camera and LAS X
software (Leica, Wetzlar, Germany), with images captured
at ×40,000 magnification. PAS stained sections were
captured in bright field with the same exposure time, gain,
brightness, contrast and offset settings brightness across
all samples, whilst corresponding fluorescence images for
determining fibre type were captured by a simple shift
Figure 2. Region-specific image analysis
A grey scale image was created of both BODIPY 493/503 staining (A)
and the cell membrane (labelled using WGA Alexa Fluor 633
conjugate) (B). A 2 μm region was identified within the inside of the
membrane (C). LD were then identified in this 2 μm (peripheral)
region (D) in addition to the remainder of the cell (central region) (E).
Scale bars represent 30 μm.
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in filters with images captured using the excitation filter
(465–495 nm) in the green channel.
To assess fibre-specific muscle glycogen content, fibres
that were positively stained for myosin heavy chain
type I were classified as type I fibres and all remaining
fibres negatively stained were classified as type II fibres.
Unfortunately, we could not acquire a positive stain for
type IIa/x fibres due to interaction effects between the
current dye and antibodies used. The entire available
muscle cross-section per biopsy sample was imaged in
order to capture as many muscle fibres as possible.
Image processing was completed using Image-Pro Plus 5.1
software (Media Cybernetics,MD,USA). To assessmuscle
glycogen content, the bright-field image of the PAS stain
was converted post hoc to 8-bit greyscale values (0–255).
The mean optical density of the PAS-stained muscle
fibres was determined by averaging the optical density
measured in every pixel in the cell, corrected for the
mean optical density of the background stain, containing
no muscle fibres. The relative staining intensity of each
muscle fibre was classified into 4 separate sections based
of optical density increments of 25% in order to visualise
the relative scale of semi-quantitative glycogen content
(empty, partially empty, partially full and full). The 25%
increment sections were calculated from the lowest to the
highest recorded optical density value within the current
data set. For PAS analysis, on average per subject, a total
of 154 ± 101 muscle fibres were analysed (85 ± 54 type
I, 76 ± 51 type II). This number of analysed muscle
fibres was in line with previous studies that detected
significant differences in fibre-specific muscle glycogen
utilisation during prolonged endurance-based exercise
with and without CHO supplementation (De Bock et al.
2007; Stellingwerff et al. 2007a).
SDS page and western blot analysis
Approximately 20 mg of frozen tissue was homogenised
in 200 μl of ice-cold 1× RIPA lysis buffer (Sigma Aldrich,
UK) supplemented with protease and phosphatase
inhibitors (Pierce, Thermo Scientific, Denmark), rotated
end over end at 4°C for 1 h and centrifuged at 12,000 g
for 10 min at 4°C. Following the determination of protein
quantification via BCA assay (Pierce, Thermo Scientific,
Denmark), each sample was resuspended in 4× Laemmli
buffer, denatured by boiling for 5 min at 95°C and
separated by SDS-PAGE using 12% TGX Precast Mini
Protein stain-free gels After electrophoresis, stain-free
gels were activated according to the manufacturer’s
instructions and semi-dry transferred to nitrocellulose
membranes (TransBlot Turbo, Bio-Rad, UK). Following
transfer, a stain-free image was obtained for total protein
loading normalisation. Membranes were subsequently
blocked in Tris-buffered saline-Tween (TBST; 0.19 m
Tris pH 7.6, 1.3 m NaCl, 0.1% Tween-20) containing 5%
non-fat milk for 1 h and incubated in primary antibodies
for AMPKα (CST: 2532), p-AMPKThr172 (CST: 2531),
p38MAPK (CST: 9212), p-p38MAPKThr180/Tyr182 (CST:
9211), CaMKII (CST: 3362), p-CaMKIIThr268 (CST: 3361),
p53 (CST: 9282), p-p53Ser15 (CST: 9281), CREB (CST:
9197), p-CREBSer133 (CST: 9198) before incubation in
a relevant secondary antibody (anti-rabbit: CST: 7074)
at a concentration of 1:2000 at room temperature the
following morning. After washing (3 × 5 min in TBST),
membranes were incubated in a chemiluminescence
substrate (Thermo Fisher Scientific, UK) and visualised
using a Chemi-doc MP system (Bio-Rad, UK) with
band densities quantified using Image Lab software
(Bio-Rad, UK). The volume density of each target band
was normalised to the total amount of protein loaded into
each lane using Stain-Free technology.
Statistical analysis
All statistical analyses were performed using Statistical
Package for the Social Sciences (SPSS Statistics Version
26, IBM, USA). Changes in exercise capacity, total
substrate oxidation, and post-exercise capacity test
blood metabolites were analysed using a one-way
repeated-measures general linear model (GLM), where
the within-subject factor was condition. Metabolic (i.e.
blood metabolites and muscle glycogen), molecular
(i.e. activity of signalling molecules), physiological and
perceptual responses during exercise (i.e. heart rate,
RPE, oxidation rates) were analysed with a two-way
repeated-measures GLM, where the within factors
were time and condition. To assess differences in
IMTG, we hypothesised a priori that IMTG content
would be significantly different between type I and IIa
fibres, as based on previous work (Van Loon, 2004;
Stellingwerff et al. 2007a; Jevons et al. 2020). Thus,
we used a three-factor repeated measures ANOVA for
comparisons of pre-exercise IMTG content (% area
stained) and LD morphology where the within factors
were condition, region and fibre. Similarly, changes in
IMTG content (% area stained), LD morphology and
the relative distribution of IMTG content between sub-
cellular regions within each fibre during exercise were
also analysed with a three-factor repeated measures
ANOVA, where the within factors were condition, region
and time. Moreover, comparisons of IMTG breakdown
were also analysed with a three-factor repeated measures
ANOVA, where the within factors were condition, region
and fibre. Linear mixed modelling was used to examine
the dependent variable, fibre-specific skeletal muscle
glycogen content, at immediately before and after the
180 min submaximal cycle with data separated into
the three different experimental conditions (0, 45 and
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Table 1. Heart rate, RPE, exercise intensity (%V̇O2 max) and energy expenditure during the 180 min submaximal steady-state cycling
protocol
Time (min)
30 60 90 120 150 180
Heart rate (beats min−1)
0 gh−1 149 ± 13 151 ± 14 153 ± 16 155 ± 14a,c 160 ± 10a,c 160 ± 10a,c
45 gh−1 148 ± 10 150 ± 12 150 ± 9 153 ± 9a,c 157 ± 7a,c 159 ± 8a,c
90 gh−1 153 ± 11 156 ± 14 157 ± 11 159 ± 14a,c 159 ± 13a,c 159 ± 14a,c
RPE (AU)
0 gh−1 13 ± 2 14 ± 1a 14 ± 2a,b 15 ± 1a,b,c 17 ± 2a,b,c,d 18 ± 2a,b,c,d,e
45 gh−1 13 ± 2 13 ± 2a 14 ± 2a,b 15 ± 2a,b,c 16 ± 2a,b,c,d 17 ± 2a,b,c,d,e
90 gh−1 13 ± 2 14 ± 2a 14 ± 2a,b 15 ± 2a,b,c 16 ± 2a,b,c,d 16 ± 3a,b,c,d,e
% V̇O2 max
0 gh−1 66 ± 4 66 ± 5 68 ± 5a 68 ± 4a,b 69 ± 4a,b,c 69 ± 5a
45 gh−1 67 ± 5 67 ± 6 68 ± 5a 69 ± 4a,b 70 ± 5a,b,c 70 ± 5a
90 gh−1 67 ± 3 68 ± 4 69 ± 4a 69 ± 4a,b 69 ± 4a,b,c 67 ± 4a
Energy expenditure (kJ·min−1)
0 gh−1 61.5 ± 3.1 61.6 ± 3.8 62.0 ± 4.1 62.2 ± 3.8 62.6 ± 3.5 61.6 ± 5.4
45 gh−1 62.8 ± 4.1 62.8 ± 4.3 62.8 ± 4.6 63.5 ± 4.1 63.4 ± 4.2 63.2 ± 4.6
90 gh−1 62.9 ± 4.3 62.8 ± 4.9 63.4 ± 5.3 63.5 ± 5.4 63.3 ± 6.0 62.1 ± 5.0
a
Significant difference from 30 min time point,
b
significant difference from 60 min time point,
c
significant difference from 90 min time point,
d
significant difference from 120 min time point and
e
significant difference from 150 min time point, P < 0.05.
90 g h−1 CHO). All main effects and interactions were
tested using a linear mixed-effects model, with random
intercepts to account for repeated measurements within
subjects to examine differences between experimental
conditions, fibre type and time. Post hoc LSD tests were
used in all statistical models where significant main
effects and interactions were observed in order to locate
specific differences. All data in text, figures and tables are
presented as means ± SD, with P values ≤ 0.05 indicating
statistical significance.
Results
CHO feeding alters circulating metabolites and
whole-body substrate utilisation
Heart rate, oxygen uptake and RPE increased during
exercise (P= 0.027, P< 0.001 and P< 0.001, respectively)
though no differences were apparent between trials
(P = 0.349, 0.725 and 0.328, respectively) (see Table 1).
Plasma lactate (P < 0.001), NEFA (P < 0.001), glycerol
(P < 0.001) and β-OHB (P < 0.001) all displayed
significant changes during exercise (see Fig. 3). In
accordance with the increased dose of CHO, there was
a significant difference between conditions for plasma
glucose (P < 0.001), NEFA (P = 0.005), glycerol
(P < 0.001) and β-OHB (P = 0.002) (see Fig. 3).
Rates of whole-body CHO oxidation progressively
decreased during exercise (P < 0.001) with a significant
difference also evident between conditions (P = 0.005)
(see Fig. 4). Total CHO oxidation was significantly
different between trials (P = 0.005) and was 315 ± 74,
386 ± 67 and 412 ± 69 g for 0, 45 and 90 g h−1 trial,
respectively, of which the 0 g h−1 trial was significantly
different from the 45 and 90 g h−1 (P = 0.030 and
0.004) (see Fig. 4). Fat oxidation increased during
exercise (P < 0.001) with a significant difference between
conditions (P= 0.034) (see Fig. 4). Total fat oxidation was
significantly different between trials (P = 0.035) and was
139 ± 23, 113 ± 17 and 104 ± 22 g for 0, 45 and 90 g h−1,
respectively, of which the 0 g h−1 trial was significantly
different from 90 g·h−1 (P < 0.001) (see Fig. 4). RER
significantly decreased during exercise (P < 0.001) with
a significant difference between conditions (P = 0.019).
Rates of energy expenditure did not significantly change
during exercise (P = 0.420) or differ between conditions
(P = 0.386) (see Table 1).
During the first hour of exercise, the contribution of
CHO towards total energy expenditure was significantly
greater than fat (P < 0.001) and there was no significant
difference between trials (P= 0.07) (see Fig. 4). During the
second hour of exercise, CHO also contributed a greater
proportion of energy expenditure than fat (P = 0.029)
and furthermore, CHO contributed a greater energy yield
© 2021 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
10 J. M. Fell and others J Physiol 0.0
in the 45 and 90 g h−1 trials compared with the 0 g h−1
trial (P = 0.014 and P = 0.005, respectively) (see Fig. 4).
During the final hour of exercise, however, there was no
significant difference between the contribution of CHO
and fat towards total energy expenditure (P = 0.06)
though CHO again contributed a greater energy yield
in the 45 and 90 g h−1 trials compared with the
0 g h−1 trial (P = 0.015 and P = 0.001, respectively)
(see Fig. 4). Visual representation of the ‘crossover
point’ (i.e. where lipid provided the largest contribution
Figure 3. Effects of exercise and carbohydrate feeding on circulating metabolites and whole muscle
glycogen
Plasma glucose (A), lactate (B), glycerol (C), NEFA (D) and β-OHB (E) responses before and during the 180 min sub-
maximal exercise. F, whole-muscle glycogen concentration before and after the 180 min submaximal exercise
protocol. ∗Significant difference from 0 g h−1, #significant difference from 45 g h−1, P < 0.05. aSignificant
difference from 0 min, bsignificant difference from 30 min, csignificant difference from 60 min, dsignificant
difference from 90 min, esignificant difference from 120 min and fsignificant difference from 150 min, P < 0.05.
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Figure 4. Effects of exercise and carbohydrate feeding on whole-body substrate utilisation
A, carbohydrate oxidation rates during exercise; B, total carbohydrate oxidation from exercise; C, fat oxidation rates
during exercise; D, total fat oxidation from exercise; E, respiratory exchange ratio (RER) during exercise; F, total
energy expenditure during the first hour of exercise;G, total energy expenditure during the second hour of exercise;
H, total energy expenditure during the third hour of exercise. ˆSignificant main effect between carbohydrate and
fat contribution to total energy expenditure, ∗significant difference from 0 g h−1, P < 0.05. aSignificant difference
from 30 min, bsignificant difference from 60 min, csignificant difference from 90 min, dsignificant difference from
120 min, esignificant difference from 150 min, P < 0.05.
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towards total energy contribution) is also presented in
Fig. 5.
CHO feeding does not alter subcellular and muscle
fibre-specific IMTG use during exercise
Pre-exercise IMTG content and LD morphology. Type I
muscle fibres had greater IMTG content compared to type
IIa fibres (P < 0.001) (see Table 2). IMTG content was
more concentrated in the periphery of the cell (within
the 2 μm border) compared with the central region
(P = 0.003; see Table 2). Overall, though, the majority
of IMTG was observed in the central compared with the
peripheral region of the cell (P < 0.001; see Table 3).
There was also a greater number (P = 0.001; see Table 2)
and size of LD (P = 0.012; see Table 2) in type I fibres
comparedwith type IIa fibres. Thus, pre-exercise fibre type
differences in IMTGcontent were explained by differences
in both LD number and size.
Effects of CHO feeding and exercise on IMTG and LD
morphology. Exercise decreased IMTG content in type I
(P< 0.001) and type IIa fibres (P= 0.002), the magnitude
of which was not affected by CHO feeding during exercise
(type I: P= 0.489; type IIa: P= 0.841) (see Fig. 6). As such,
there was no difference in the net breakdown of absolute
IMTGbetween trials (main condition effect;P= 0.152; see
Fig. 6). A greater net IMTG breakdown was also observed
in type I compared to type IIa fibres (P< 0.001; see Fig. 6).
When examining exercise-induced changes on a
subcellular-specific basis, IMTG content was significantly
reduced in both the peripheral (P < 0.001; type IIa:
P = 0.016) and central regions (type I: P < 0.001; type
IIa: P = 0.001) of both fibres (see Fig. 6). Additionally,
the relative contribution of IMTG across the subcellular
Figure 5. Rates of energy provision from carbohydrate and fat oxidation during exercise
Rates of energy provision from carbohydrate (CHO) and fat oxidation during the 0 (A), 45 (B) and 90 g h−1 (C) trials.
D, individual time points at which the crossover point occurred whereby fat provided the predominant contribution
to energy expenditure (note, no individual data points are provided for those individuals who displayed no crossover
contribution time point within a specific trial).
© 2021 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.



































































































































































































































































































































































































































































































































































































regions within type I fibres decreased in the central
region (P = 0.001), with a reciprocal increase in the
relative distribution of IMTG within the peripheral
region (P = 0.001) (see Table 3). In contrast, the relative
distribution within type IIa fibres remained similar after
exercise (P = 0.141) (see Table 3).
Figure 6. Fibre type and subcellular-specific changes in IMTG
content before and after the 180 min submaximal exercise
protocol
IMTG content in each region was normalised to total cell area.
Shown are IMTG content in type I (A) and type IIa (B) muscle fibres
and net IMTG breakdown (C). #Significant reduction in IMTG content
from 0 min, P < 0.05. ˆSignificant region × time interaction from
0 min, P < 0.05. ∗Significantly different from type I fibres, P < 0.05.
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Table 3. Relative distribution of IMTG between subcellular regions before and after the 180min submaximal cycling exercise protocol
Percentage of IMTG
Type I fibres Type IIa fibres
Peripheral Central∗ Peripheral Central∗
0 min
0 gh−1 16 ± 6 84 ± 6 19 ± 7 81 ± 7
45 gh−1 16 ± 5 84 ± 5 18 ± 6 82 ± 6
90 gh−1 14 ± 3 86 ± 3 14 ± 4 86 ± 4
180 min
0 gh−1 22 ± 15# 78 ± 15# 18 ± 7 82 ± 7
45 gh−1 25 ± 13# 75 ± 13# 22 ± 13 78 ± 13
90 gh−1 19 ± 7# 81 ± 7# 15 ± 5 85 ± 5
∗Significant effect of region across all time points, P < 0.05.
#
Significantly different from 0 min time point within same condition, P < 0.05.
When examining changes in LD morphology, LD
number reduced significantly in both type I (P < 0.001)
and type IIa muscle fibres (P = 0.001) with no effect of
CHO feeding in either fibre type (type I: P = 0.417; type
IIa: P = 0.975) (see Fig. 7). LD number decreased in
both the central and peripheral regions within both type
I (P < 0.001) and type IIa fibres (P = 0.001) (see Fig. 7).
However, LD size was significantly smaller after exercise
in type I muscle fibres only (P = 0.004), with reductions
in both the peripheral (P= 0.011) and central (P= 0.005)
regions (see Fig. 7).
Thus, IMTG utilisation during exercise could be
explained by a decrease in LD number within the peri-
pheral and central regions of both type I and IIa fibres
but a reduction in LD size occurred exclusively in type I
fibres. Figure 8 depicts a visual representation of IMTG
content in type I and IIa fibres at 0 min and after 180 min
of submaximal cycling exercise in the 0, 45 and 90 g h−1
condition.
CHO feeding does not alter whole-muscle or
fibre-specific muscle glycogen during exercise
In accordance with the 36 h dietary standardisation
protocol, subjects presented as CHO loaded where
there was no difference in pre-exercise muscle glycogen
concentration between trials (P= 0.137; 0 g h−1: 767± 87,
45 g h−1: 742 ± 109, 90 g h−1: 698 ± 98 mmol kg−1
DW). Exercise induced significant decreases in muscle
glycogen to comparable levels immediately after the sub-
maximal cycle (P < 0.001; 0 g h−1: 252 ± 85, 45 g h−1:
269 ± 88, 90 g h−1: 293 ± 109 mmol·kg−1 DW) and no
differences were apparent between conditions (P= 0.783)
(see Fig. 3). Muscle glycogen was reduced to a greater
extent in type I compared to type II fibres (P< 0.001) and
CHO feeding did not alter glycogen utilisation in either
fibre type (P= 0.309) (see Fig. 9). Figure 10 depicts a visual
representation of glycogen content in type I and II fibres
at 0 min and after 180min of submaximal cycling exercise
in the 0, 45 and 90 g h−1 conditions. Muscle glycogen
content was reduced by 41 ± 16, 35 ± 12 and 30 ± 18%
in type I fibres and by 7 ± 8, 11 ± 11 and 9 ± 14% in
type II fibres for the 0, 45 and 90 g h−1 trial, respectively.
Further representation of the relative scale of glycogen
depletion within type I and type II fibres is presented in
Fig. 11.
CHO feeding does not attenuate skeletal muscle cell
signalling pathways with regulatory roles in
promoting training adaptation
Exercise significantly increased the phosphorylation of
AMPKThr172 (P < 0.001) although increases (∼4-fold)
were similar between conditions (P= 0.851) (see Fig. 12).
Similarly, exercise increased the phosphorylation of
both CaMKIIThr286 (2-fold; P = 0.003) and p53Ser15
(2-fold; P = 0.025) independently of CHO availability
(P = 0.360 and P = 0.784, respectively) (see Fig. 12).
In contrast, neither p38 MAPKThr180/Tyr182 (main
effect of condition; P = 0.645, time; P = 0.064) nor
CREBSer133 (main effect of condition; P = 0.601, time;
P = 0.733) (see Fig. 12) phosphorylation was significantly
altered by either exercise or CHO availability, which
both displayed large inter-individual variance in their
responses. Representative western blots are displayed in
Fig. 12.
CHO feeding improves exercise capacity in a dose
dependent manner
Exercise capacity was increased in a dose dependent
manner where the 90 g h−1 trial (233 ± 133 s) was
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greater than the FAM (87 ± 63 s; P = 0.005: 95% CI for
differences = 62 to 232 s), 0 g h−1 (108 ± 54; P = 0.013:
95% CI for differences = 35 to 215 s) and 45 g h−1
(156± 66 s;P= 0.06: 95%CI for differences=−4 to 158 s)
trials (see Fig. 13). The 45 g h−1 dose was also longer than
the FAM (P = 0.035: 95% CI for differences = 6 to 133 s)
and 0 g h−1 (P= 0.029: 95% CI for differences= 7 to 89 s)
trial, whilst therewas no significant difference between the
0 g h−1 and FAM (P= 0.299: 95%CI for differences=−24
to 68 s) trial (see Fig. 13). Therewas a significant difference
in capacity times when data were analysed for a trial order
effect (P = 0.05) but this was due to a significant increase
in capacity time between FAM and the first experimental
trial (P = 0.005: 95% CI for differences = 45 to 179 s)
with no other pairwise differences present (see Fig. 13).
Plasma glucose (P = 0.004), NEFA (P = 0.003), glycerol
(P = 0.001) and β-OHB (P = 0.002) were all significantly
different between conditions at exhaustion (see Fig. 14),
whilst lactate (P = 0.277) was not different between
trials.
Discussion
Confirming our hypothesis, our data demonstrate that
CHO feeding during prolonged endurance exercise does
not alter IMTG and glycogen utilisation in either type
I or type II/IIa muscle fibres. Moreover, we also present
novel data on the subcellular-specific changes in IMTG
content and LD morphology during exercise, in that we
observed for the first time that IMTG content was reduced
in both the peripheral and central regions of both fibres,
an effect independent of CHO feeding. The reduction
of IMTG content was a function of a reduction in LD
number in both type I and IIa fibres, whereas a reduction
in LD size was only evident in type I fibres. In accordance
with similar absolute glycogen utilisation and depletion,
CHO feeding did not attenuate activation of acute cell
signalling pathways with regulatory roles in modulation
of skeletal muscle mitochondrial biogenesis. Finally, CHO
feeding improved exercise capacity in a dose dependent
manner, an effect likely to be related to maintenance of
Figure 7. Fibre type and subcellular-specific changes in lipid droplet (LD) morphology before and after
the 180 min submaximal exercise protocol
LD number in each region was normalised to total cell area. Shown are LD number in type I (A) and type IIa (B)
muscle fibres, and LD size in type I (C) and type IIa (D) muscle fibres. #Significant reduction from 0 min, P < 0.05.
ˆSignificant region × time interaction from 0 min, P < 0.05.
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circulating glucose availability and whole-body rates of
CHO oxidation.
We employed an experimental design that evaluated
muscle fuel selection in a manner that is aligned with the
nutritional practices often adopted by endurance athletes,
i.e. CHO availability was increased in the day(s) and
hours before competition so as to commence exercise
with sufficient muscle and liver glycogen stores (Burke
et al. 2018). In accordance with the trained status of
our participants and the 36 h CHO loading protocol,
our model was successful in achieving highly elevated
pre-exercise glycogen stores, as evidenced by whole
muscle glycogen concentrations (see Fig. 3) and the dark
PAS staining in both type I and type II muscle fibres
(see Fig. 10). In agreement with previously documented
storage patterns of IMTG (Van Loon et al. 2003a,b; De
Bock et al. 2005; Stellingwerff et al. 2007a; Shepherd
et al. 2013; Jevons et al. 2020), we also observed that
resting IMTG stores were twofold greater in type I fibres
compared to type IIa fibres (see Table 2). Additionally,
IMTG content was more concentrated in the peri-
phery of the cell compared with the central region, as
also documented in previous studies utilising immuno-
fluorescence analysis with a similar peripheral region
classification (a fixed 2 μm region from the cell border)
(Jevons et al. 2020). The fibre type specific difference in
Figure 8. Representative immunofluorescence images of intramuscular triglycerides (IMTG) in response
to prolonged endurance exercise with and without carbohydrate (CHO) feeding during exercise in type
I and IIa muscle fibres
Sections were stained for IMTG (stained using BODIPY 493/503; green), fibre type (type I: primary antibody MHCI
– A4.840c; secondary antibody goat anti-mouse IgM 546, red; type IIa: MHCIIa – N2.261c; secondary antibody
goat anti-mouse goat anti-mouse IgG 405, blue), and wheat germ agglutinin Alex Fluor 633 to identify cell border
(stained pink). Images depict IMTG content in type I (stained red) and IIa fibres (stained blue) at 0 min and after
180 min of submaximal cycling exercise. Scale bars represent 30 μm.
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resting IMTG was a function of a greater number and size
of LDs in type I fibres compared with type IIa fibres (see
Table 2), also consistent with recent observations from
our laboratory in male endurance trained participants
(Jevons et al. 2020). Importantly, the resting storage
pattern of both IMTG and muscle glycogen was not
different between trials, thus demonstrating that the
36 h exercise and dietary protocol was successful in
Figure 9. Fibre type changes in muscle glycogen content
before and after the 180 min submaximal exercise protocol
Muscle glycogen content in type I (A) and type II (B) fibres before
and after the 180 min submaximal cycling exercise protocol, as
determined on periodic acid-Schiff-stained muscle cross-sections. C,
net muscle glycogen utilisation. #Significantly different from 0 min,
P < 0.05. ∗Significantly different from type I fibres, P < 0.05.
ensuring similar substrate availability prior to the main
experimental trial. Nonetheless, we acknowledge that
our dietary standardisation protocol could be considered
sub-optimal in relation to dietary fat intake (i.e. 1 g kg−1)
since it has previously been shown that ∼2 g kg−1 day−1
is required to fully replenish IMTG stores within 48 h of
the last exercise bout (Van Loon et al. 2003b). However,
we chose to replicate previous dietary approaches from
our laboratory (Impey et al. 2016), given that our focus
was to primarily maximise CHO availability for the main
experimental trial.
Our submaximal exercise protocol induced an
approximate 50% decrease in IMTG content within
type I fibres, a magnitude of utilisation that agrees well
with previous studies also utilising cycling protocols
lasting ≥ 3 h (Van Loon et al. 2003b; Stellingwerff et al.
2007a,b; Jevons et al. 2020). Although previous studies
have reported IMTG degradation to be negligible within
type II (Van Loon et al. 2003a,b; Stellingwerff et al.
2007a,b) and IIa (De Bock et al. 2005; Van Proeyen
et al. 2011; Jevons et al. 2020) fibres, we observed an
approximate 30% utilisation of IMTG stores within type
IIa fibres. Our data therefore agree with observations
from well-trained cyclists whereby a 32% reduction in
IMTG content in type II fibres was reported following 3 h
of steady-state cycling at 62% V̇O2 max (Stellingwerff et al.
2007b). Additionally, an approximate 45% depletion of
IMTG has also been observed in type IIa fibres during
2 h of prolonged cycling when examined after 6 weeks
of consistent endurance training in the fasted state (Van
Proeyen et al. 2011).
From a subcellular-specific perspective, we provide
novel data by demonstrating that the exercise-induced
decrease in IMTG content in both fibre types occurred
within both the central and peripheral regions. This
pattern of utilisation is in contrast to previous reports
within our laboratory using a similar lipid dye (BODIPY
493/503) where Jevons et al. (2020) observed that only
the central region type I fibres displayed reduced IMTG
content. The reduction in IMTG content observed in
the present study was also due to a reduction in LD
number in both type I and IIa fibres whereas a reduction
in LD size was only evident in type I fibres. Our data
are in agreement with previous observations that have
also reported a reduction in both LD size and number
in type I fibres following 1 h (Shepherd et al. 2013),
2 h (Van Loon et al. 2003a) and 3 h (Stellingwerff et al.
2007a) of moderate intensity cycling exercise. In contrast,
Jevons et al. (2020) observed that the decrease in IMTG
content in type I fibres after a 4 h cycling protocol
at ∼56 V̇O2 max was the consequence of a reduction
in LD number with no difference in LD size. Inter-
estingly, the reduction in LD number primarily under-
pinning the decrease in IMTG content in type IIa
fibres has not been previously reported in the literature
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Figure 10. Representative images of
muscle glycogen in response to
prolonged endurance exercise with and
without carbohydrate (CHO) feeding
during exercise
Sections were stained for glycogen (periodic
acid-Schiff (PAS)), fibre type (primary
antibody MHCI – A4.840c; secondary
antibody goat anti-mouse IgM 488, green).
Images depict glycogen content in type I
and II fibres at 0 and 180 min in the 0, 45
and 90 g h−1 conditions. Scale bars
represent 50 μm.
© 2021 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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following prolonged moderate intensity exercise (>2 h).
As such, it is difficult to compare this finding with pre-
vious research, but such observations may be partially
explained by the oxidative nature of type IIa fibres within
endurance-trained individuals compared to untrained or
less trained individuals.Moreover, there is also a large level
of recruitment of the m. vastus lateralis during prolonged
cycling, which would therefore require high energy
demand from both fibre types. When taken together,
our data present novel findings in relation to IMTG
utilisation in type IIa fibres as well as subcellular-specific
IMTG utilisation. Such differences between the present
and aforementioned studies may be methodological in
nature and a reflection of different immunohistochemical
staining techniques. Indeed,most of these aforementioned
studies assessed IMTG content through the use of ORO
lipid dye (Van Loon et al. 2003a,b; De Bock et al. 2005;
Stellingwerff et al. 2007a,b) whilst the present study
utilised an alternative dye, BODIPY493/503. The different
lipid dyes have important methodological considerations
given that ORO does not exclusively stain IMTG but
also labels all neutral lipids (e.g. phospholipids within
Figure 11. Relative fibre-specific muscle glycogen content before and after the 180 min submaximal
exercise protocol
Relative glycogen content in 0 and 180 min sections in 0 g h−1 type I (A), 0 g h−1 type II (B), 45 g h−1 type I (C),
45 g h−1 type II (D), 90 g h−1 type I (E), and 90 g h−1 type II (F) muscle fibres. Data are presented as percentage
of fibres categorised within optical density increments of 25% from the lowest recorded optical density to the
highest value across all samples.
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Figure 12. Effects of exercise and carbohydrate feeding on skeletal muscle cell signalling pathways
AMPKThr172 phosphorylation (A), p38Thr180/Tyr182 phosphorylation (B), p53Ser15 phosphorylation (C), CREBSer133
phosphorylation (D) and CaMKIIThr286 phosphorylation (E) at 0 and 180 min. F, representative western blot images.
#Significantly different from 0 min, P < 0.05.
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membranes) and recent comparisons between the two
suggest that BODIPY detects greater amounts of IMTG
content compared to ORO in all fibre types (Strauss et al.
2020). Additionally, differences in the quantification of the
subcellular utilisation of IMTG are also evident with the
use of the different dyes, as comparisons showed IMTG
utilisation to be specific to the peripheral region when
examined using ORO whilst utilisation was of a similar
magnitude in the peripheral and central region with the
use of BODIPY 493/503 (Strauss et al. 2020).
Despite examining both central and peripheral IMTG
utilisation, it is currently difficult to ascertain the precise
functional role of these subcellular pools. Nonetheless,
it has been suggested that the central IMTG pool is the
preferred fuel source for the central mitochondria, thus
providing energy for muscle contraction (Hood, 2001).
The central mitochondria also contain increased levels of
oxidative phosphorylation proteins and increased activity
of the respiratory chain complex (Ferreira et al. 2010).
As such, the central mitochondria appear specialised
towards energy production for contractile function and
may therefore rely on the central IMTG pool. In contrast,
the peripheral IMTG pool presumably supply the peri-
pheral mitochondria and potentially provide energy for
membrane related processes (Hood, 2001). Future work
utilising transmission electron microscopy (TEM) (given
its greater magnification capabilities and resolving power)
is warranted to further investigate LD utilisation and
mitochondrial content within these subcellular regions.
We also observed that the magnitude of IMTG
degradation in both type I and IIa fibres was not affected
by CHO feeding during exercise, thus demonstrating that
an IMTG sparing effect did not occur (see Fig. 6). These
findings are consistent with previous suggestions that
the ingestion of 50 g h−1of glucose during exercise does
not alter skeletal muscle IMTG utilisation during 3 h of
moderate intensity cycling exercise (Stellingwerff et al.
2007a). In contrast, De Bock et al. (2005) observed an
attenuated use of IMTG in type I fibres with 2.5 g kg−1
(∼150 g) and 1 g kg h −1 (∼75 g h−1) of CHO intake before
and during 2 h of a more intense cycling protocol (∼75%
of V̇O2 max) compared to completing the exercise trial after
an overnight fast. It is possible that the consumption of a
pre-exercise meal across all trials in the present study may
have offset any potential regulatory effects of CHO feeding
during the exercise bout itself. In this way, the metabolic
differences between trials (e.g. hormonal milieu and sub-
strate availability) during the initial 60–90 min of exercise
may not have been sufficient to alter the pattern of IMTG
use. This is especially relevant given that IMTG utilisation
appears to predominate during the first 2 h of exercise,
with an attenuated use thereafter (Romijn et al. 1993;Watt
et al. 2002). Indeed, although a progressive difference in
plasma NEFA availability and delivery during the third
hour of exercise (see Fig. 3) may have suppressed IMTG
mobilisation and/or oxidation (Watt et al. 2002; Van Loon
et al. 2003a, 2005; Watt et al. 2004a), it is possible that
the predominant IMTG utilisation had already occurred
during the first 1–2 h of exercise. Such a hypothesis
is supported by the observation that whole body rates
of fat oxidation did not differ between trials until the
second and third hour of exercise (see Fig. 4). It is also
noteworthy that although glucose consumption during
exercise has previously been shown to suppress skeletal
muscle hormone sensitive lipase activity, this was not
associated with alteration to estimated IMTG oxidation
(Watt et al. 2004b).
Similar to IMTG, we observed greater relative glycogen
depletion in type I fibres compared with type II muscle
fibres, the magnitude of which was not affected by
CHO feeding during exercise (see Fig. 9). The absence
of a glycogen sparing effect is in contrast to pre-
vious reports demonstrating that CHO feeding exerts
glycogen sparing in type I (Stellingwerff et al. 2007a) and
Figure 13. Effects of carbohydrate feeding on exercise capacity
Exercise capacity time (time to exhaustion) during the familiarisation (FAM), 0, 45 and 90 g h−1 trials (A), and trial
order exercise capacity time (B). ∗Significantly different from FAM, P < 0.05. #Significantly different from 0 g h−1,
P < 0.05. $Significantly different from 45 g h−1, P = 0.06. Bars represent group means and symbols represent
individual data points.
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type II fibres (De Bock et al. 2007; Stellingwerff et al.
2007a). Such discrepancies between studiesmay be under-
pinned by methodological differences that are related to
muscle glycogen availability, pre-exercise CHO feeding,
exercise duration and timing of assessment of substrate
metabolism. In relation to the latter, Stellingwerff et al.
(2007a) observed that the glycogen sparing effect in
type I and type II fibres was due to a reduction in
muscle glycogen utilisation in the first hour of exercise,
as evidenced by stable isotope methodology. These
researchers also used a dietary protocol in which sub-
jects commenced exercise in the fasted state and after
consuming ∼6 g kg−1 CHO per day for 2 days. Given
the greater CHO availability associated with the pre-
sent dietary protocol (i.e. a true CHO loading protocol
as well as consumption of a pre-exercise high CHO
meal), it is possible that any potential regulatory effects
of consuming CHO ‘during’ exercise are offset by the
effects of higher pre-exercise muscle glycogen availability
on absolute muscle glycogen utilisation (Hargreaves et al.
1995; Arkinstall et al. 2004). Despite using similar dietary
conditions to those adopted here (i.e. consumption of
a pre-exercise CHO meal of 2.5 g kg−1 in the CHO
fed trial), De Bock et al. (2007) observed a glycogen
Figure 14. Circulating metabolite responses immediately after the exercise capacity test
Plasma glucose (A), lactate (B), glycerol (C), NEFA (D), β-OHB (E) responses immediately after the exercise capacity
test. ∗Significant difference from 0 g h−1, #significant difference from 45 g h−1, P < 0.05. Bars represent group
means and symbols represent individual data points.
© 2021 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
J Physiol 0.0 CHO feeding, muscle metabolism and cell signalling 23
sparing effect in type IIa fibres whereas we observed no
such effect. Given the well documented effects of exercise
duration on glycogen utilisation (Areta & Hopkins,
2018) coupled with the selective recruitment of type II
fibres as type I fibres become depleted (Gollnick et al.
1973), it is possible that discrepancies between studies
in this instance are simply a reflection of a greater
exercise duration (i.e. 3 vs. 2 h cycling protocol). Such
findings highlight the need for future studies to assess
the time course of fibre-specific muscle glycogen use
during prolonged endurance exercise. In addition, the
assessment of glycogen utilisation within distinct sub-
cellular pools of both type I and II muscle fibres (through
the use of quantitative TEM) is also warranted to provide a
more complete understanding of glycogen utilisation with
CHO feeding. This is especially relevant given the recent
findings that endurance capacity is associated with intra-
myofibrillar glycogen content within type I fibres and that
supercompensation of the subsarcolemmal glycogen pool
(via CHO loading) reduces the utilisation of the intra-
myofibrillar glycogen pool during exercise (Jensen et al.
2020).
In relation to cell signalling pathways, CHO feeding
did not affect exercise-induced activation of upstream
(e.g. AMPKThr172 and CaMKIIThr268 phosphorylation) or
downstream signalling (e.g. p53Ser15 phosphorylation)
proteins with regulatory roles in mitochondrial
biogenesis. In contrast to AMPK, we did not observe
any change in the phosphorylation status of p38
MAPKThr180/Tyr182 in response to exercise or CHO feeding,
though we note the large inter-individual variability
between subjects. When considered with previous
data demonstrating that p38 MAPK phosphorylation
is unaltered by muscle glycogen concentration (Yeo
et al. 2010; Bartlett et al. 2013; Hammond et al. 2019)
or pre-exercise CHO feeding (Stocks et al. 2019), our
data provide further evidence to support the notion
that CHO availability does not readily modulate the
phosphorylation of p38 MAPK in whole muscle homo-
genate. We have previously observed that both AMPK
and p53 related signalling is enhanced when exercise
is commenced and finished with high (∼500 and
∼300 mmol kg−1 DW, respectively) versus low (∼150
and ∼50 mmol kg−1 DW, respectively) muscle glycogen
(Bartlett et al. 2013). More recently, we also observed that
comparable cell signalling responses occur if exhaustive
(Hearris et al. 2019) and non-exhaustive (Hearris et al.
2020) exercise is finished with similar muscle glycogen
concentrations (i.e. <300 mmol kg−1 DW), despite
commencing exercise with graded levels of muscle
glycogen concentration. On this basis, it was suggested
that in the context of manipulating CHO availability
to potentiate cell signalling, the absolute post-exercise
muscle glycogen concentration is a more influential
factor than pre-exercise muscle glycogen concentration.
Such a line of thinking is accordance with the present
data as well as independent studies (Akerstrom et al.
2006; Lee-Young et al. 2006) demonstrating that CHO
feeding does not affect cell signalling when alterations to
muscle glycogen utilisation (i.e. glycogen sparing) has not
occurred. Such findings are likely to be underpinned by
the physical tethering of AMPK to the glycogen granule
via its ß-subunit (Steinberg et al. 2006). In this way,
comparable exercise-induced glycogen depletion may
result in dissociation of AMPK, thus allowing for similar
kinase phosphorylation. Additionally, our observation
of comparable CaMKII phosphorylation between trials
may also be underpinned by similar absolute levels of
glycogen utilisation and depletion, that is, any potential
glycogen mediated impairments in Ca2+ release from the
sarcoplasmic reticulum (Gejl et al. 2014) would be similar
between trials, thus providing a similar stimulus for Ca2+
mediated signalling.
In considering exercise capacity, we observed that CHO
feeding improved exercise capacity in a dose dependent
manner such that 90 g h−1 > 45 g h−1 > 0 g h−1.
Importantly, we utilised a CHO feeding protocol
consisting of solids, gels and fluid (in accordance with
the feeding practices of elite endurance athletes) as well
as inclusion of a full familiarisation trial. Whilst it is
difficult to directly compare between studies (given the
differences in training status, exercise protocol and CHO
source and blend), our observation that 90 g h−1 is an
ergogenic dose agrees with several recent dose-response
studies examining multiple source blends. For example,
Smith et al. (2013) estimated that 78 g h−1 CHO was
the optimal dose to maximise performance when a wide
range of doses (0 to 120 g h−1) was investigated. Indeed,
using a multiple site research protocol, these researchers
used a variety of doses of CHO (comprising a 1:1:1 ratio
of glucose, fructose and maltodextrin solution consumed
during 2 h steady-state ride at 95% onset of blood lactate
accumulation) and observed that the magnitude of
performance improvement during a subsequent 20 km
time trial (TT) was curvilinear in nature. More recently,
King et al. (2018) observed that ingestion of 90 g h−1 of
a glucose-fructose (2:1 ratio) solution during a 2 h sub-
maximal ride at 77% V̇O2 max produced the highest mean
power output during a subsequent 30 min self-paced
TT when compared with 60 and 75 g h−1 of a glucose
only solution and 112.5 g h−1 of a glucose-fructose (2:1
ratio) solution. When the same group extended exercise
duration beyond 3 h but of a lower exercise intensity
(60% V̇O2 max), the researchers reported that ingestion
of 90 g h−1 of glucose and fructose (2:1 ratio) solution
increased power output during a 30 min self-paced TT
by 6.8% and 4% when compared with 100 g h−1 and
80 g h−1, respectively (King et al. 2019). When such
studies are considered with the present data, it becomes
apparent that where exercise duration exceeds 2.5–3 h,
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the ergogenic effects of CHO feeding are likely to be most
predominant with multiple source blends comprising
75–90 g h−1.
In contrast to a muscle glycogen sparing effect, the
observed exercise capacity improvements are most likely
related to maintenance of high CHO availability, plasma
glucose concentrations and ultimately, high rates of CHO
oxidation (Coyle et al. 1986; Smith et al. 2010; Newell
et al. 2018). Indeed, although we acknowledge that our
study design did not represent a true double-blind design
(given that subjects were consciously aware of consuming
more solids in the 90 g h−1 trial), examination of sub-
strate availability and oxidation support the hypothesis
that maintenance of high rates of CHO oxidation (at
the expense of lipid oxidation) underpinned the exercise
capacity improvements observed here. Such a hypothesis
is especially evident when examining the ‘crossover point’
at which lipid oxidation comprised the largest proportion
of energy production during exercise. Indeed, these data
demonstrate that consuming 90 g h−1 of CHO delayed
the crossover point by ∼10 and ∼40 min when compared
with the 45 and 0 g h−1 trials, respectively (see Fig. 5). The
magnitude of improvement in exercise capacity between
trials is also of physiological significance given that
professional cycling races (e.g. the cycling Grand Tours)
can be won or lost with seconds.
Aside from an exercise performance perspective, our
data provide greater insights into how athletes can
implement nutritional strategies that promote training
quality without sacrificing cellular adaptation. Indeed,
there is often a belief that nutritional strategies to promote
training intensity (i.e. promotion of adequate CHO
availability) are mutually exclusive to those promoting
training adaptation (i.e. CHO restriction). However, the
present data demonstrate that trained male athletes can
still achieve these fundamental adaptive goals of training
even in the presence of high CHO availability before
and during training. Our data clearly demonstrate that
high CHO availability (i.e. high glycogen availability,
pre-exercise feeding and CHO intake during exercise)
does not impair the activation of cell signalling pathways
with regulatory roles in stimulating hallmark adaptations
to endurance training such as mitochondrial biogenesis.
Importantly, these findings were observed during an
exercise challenge that adopted an exercise duration (i.e.
> 3 h) and intensity (i.e. above lactate threshold) that is
of ‘real world’ physiological relevance to ‘elite’ endurance
athletes.
In summary, we demonstrate that CHO feeding
does not alter fibre and subcellular-specific IMTG
content, LD morphology, muscle glycogen utilisation
or exercise-induced cell signalling in human skeletal
muscle. In relation to IMTG metabolism, we report for
the first time that the exercise-induced decrease in IMTG
content occurred in both the peripheral and central
regions of both type I and IIa muscle fibres. Additionally,
we observed a reduction in LD number in both type I
and IIa fibres whereas a reduction in LD size was only
evident in type I fibres. In the absence of alterations
to muscle fuel selection, we also observed that CHO
feeding does not attenuate cell signalling pathways with
regulatory roles in mitochondrial biogenesis. Finally, the
data demonstrate that CHO feeding improves exercise
capacity in a dose dependent manner, an effect that
was associated with maintenance of circulating glucose
availability and whole-body rates of CHO oxidation.
Importantly, our assessment of substrate metabolism
was conducted under experimental conditions that are
considered best nutritional practice (i.e. after CHO
loading and consumption of CHO before and during
exercise) for elite endurance athletes.
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